Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Deals and Financings

Set Alert for Deals

M&A Analysis: Steady Goes September

Medtech M&A deal making has resumed the pace of activity seen before the brief surge in the summer. 17 M&A deals were announced and recorded on the Medtech Insight M&A deal tracker, one more than the previous month but included a few billion dollar transactions.

M & A Deals Commercial
Advertisement

Latest From Deals

Angle's Maiden M&A Fills Gaps In Liquid Biopsy Solution

By acquiring Axela Inc, liquid biopsy specialist Angle PLC will now be able to pair the Canadian firm's gene expression measurement technology with its Parsortix circulating tumor cell harvesting system. Angle will finance this transaction with the proceeds it expects to raise from a proposed £12.2m share placement.

Cancer In Vitro Diagnostics

VC Deals Analysis: Quarter-Billion Round Hikes September Takings To Five-Year High

September benefitted from two nine-figure venture financing rounds, including a $250m round by consumer genetic test service provider 23andme. These bumper deals significantly boost the total takings in 2017 so far to the extent that the year looks likely to beat 2016.

Deals Financing

EnteroMedics Inflates Neuromod-Obesity Offering With ReShape Balloon

The deal, worth $61m in cash and stock, will add ReShape's Dual Weight Loss Balloon to EnteroMedics' vBloc neurometabolic therapy and Gastric Vest System for the treatment of obesity.

Gastrointestinal M & A

Boston Scientific Adds Single-Shot AF-Ablation Balloon With Apama Acquisition

Boston Scientific will pay about $300m for the Campbell, California-based maker of the Apama radiofrequency balloon catheter system for the treatment of atrial fibrillation. Boston Scientific plans to integrate Apama's technology with its Rhythmia HDx mapping system.

Cardiology M & A

Series B Pumps $15m Into Abiomed-Backed Acute HF Start-Up

Magenta Medical Ltd, an Israeli start-up founded by cardiology veterans and backed by miniaturized heart pump specialist Abiomed, has reeled in $15m in Series B financing. The additional capital will enable the company to take its catheter-based therapy for acute heart failure through clinical trials and beyond CE-mark approval.

Cardiology Financing

Ernst & Young Bullish On Medtech's Fusion With Innovation

The medtech industry grew by 5% last year, with revenues from US- and Europe-based medtechs reaching $364.4bn in 2016. Meanwhile, net income rose by 17% to reach $16bn in 2016, according to Ernst & Young's annual medtech "Pulse of the industry" report, released today to coincide with The MedTech Conference in San Jose. With global funding expanding, in particular in Asia, medtechs are well positioned for growth, but only those willing to embrace the digital revolution are poised to win.

Commercial Deals

Pacts In Medtech, July/August 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life-sciences deals, the bimonthly Pacts In Medtech column pulls up notable technology alliances, R&D partnerships and commercial collaborations. In this edition, we highlight industry pacts that were sealed in July and August 2017.

Deals Pacts in Medtech

VC Deals Analysis: Liquid Biopsy Summons Yet Another Top A-Lister

While August may have broken the short summer bull run, last month's batch of venture fundraisings did have one redeeming feature – it recorded the biggest Series A round this year to date, a $50m deal by liquid biopsy company Karius.

Deals Financing

M&A Analysis: August Activity Cools As The Summer Closes

Medtech M&A activity slowed in the last month of summer with just 16 mergers and acquisitions recorded on the Medtech Insight M&A Deal Tracker. However, the month included one billion-dollar deal and several deals in the ophthalmological sector.

M & A Deals
See All
UsernamePublicRestriction

Register